Royce & Associates’s Caribou Biosciences CRBU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-142,912
| Closed | -$280K | – | 849 |
|
|
2024
Q3 | $280K | Hold |
142,912
| – | – | ﹤0.01% | 823 |
|
|
2024
Q2 | $234K | Sell |
142,912
-116,016
| -45% | -$190K | ﹤0.01% | 836 |
|
|
2024
Q1 | $1.33M | Buy |
258,928
+5,826
| +2% | +$29.9K | 0.01% | 692 |
|
|
2023
Q4 | $1.45M | Buy |
253,102
+228,787
| +941% | +$1.31M | 0.01% | 693 |
|
|
2023
Q3 | $116K | Buy |
24,315
+9,615
| +65% | +$46K | ﹤0.01% | 889 |
|
|
2023
Q2 | $62.5K | Hold |
14,700
| – | – | ﹤0.01% | 905 |
|
|
2023
Q1 | $78.1K | Buy |
14,700
+4,100
| +39% | +$21.8K | ﹤0.01% | 903 |
|
|
2022
Q4 | $66.6K | Buy |
+10,600
| New | +$66.6K | ﹤0.01% | 898 |
|
|
2022
Q1 | – | Sell |
-12,900
| Closed | -$195K | – | 969 |
|
|
2021
Q4 | $195K | Buy |
+12,900
| New | +$195K | ﹤0.01% | 947 |
|